Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Suspended No phase listed Observational

Longitudinal Study of Mitochondrial Hepatopathies

ClinicalTrials.gov ID: NCT01148550

Public ClinicalTrials.gov record NCT01148550. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 1:35 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The specific aims of this study are (1) to determine the clinical phenotypes and natural history of hepatic RC and FAO disorders, (2) to determine the correlation between genotype and phenotype, (3) to determine if circulating biomarkers reflect diagnosis and predict liver disease progression and survival with the native liver, (4) to determine the clinical outcome of these disorders following liver transplantation, and (5) to develop a repository of serum, plasma, urine, tissue and DNA specimens that will be used in ancillary studies. To accomplish these aims, the ChiLDReN investigators at clinical sites (currently 9 sites) will prospectively collect defined data and specimens in a uniform fashion at fixed intervals in a relatively large number of subjects. Clinical information collected from subjects and their parents will enhance the potential for meaningful research in these disorders. A biobank of previously collected subject specimens and DNA samples will be established for use in ancillary studies to be performed in addition to this study.

Study identification

NCT ID
NCT01148550
Recruitment status
Suspended
Study type
Observational
Phase
Not listed
Enrollment
90 participants

Conditions and interventions

Eligibility (public fields only)

Age range
Up to 18 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 18, 2010 (Actual)
Primary completion
May 31, 2029 (Estimated)
Completion
May 31, 2029 (Estimated)
Last update posted
Jun 4, 2026

2010 – 2029

United States locations

U.S. sites
15
U.S. states
13
U.S. cities
15
Facility City State ZIP Site status
Children's Hospital Los Angeles Los Angeles California 90027 —
University of California at San Francisco (UCSF) San Francisco California 94143 —
Children's Hospital Colorado Aurora Colorado 80045 —
Children's Healthcare of Atlanta - Emory University Atlanta Georgia 30322 —
Ann & Robert H. Lurie Children's Hospital Chicago Illinois 60611 —
Riley Hospital for Children Indianapolis Indiana 46202 —
Johns Hopkins School of Medicine Baltimore Maryland 21287 —
Washington University School of Medicine St Louis Missouri 63110 —
Mount Sinai Medical Center New York New York 10029 —
Children's Hospital Medical Center Cincinnati Ohio 45229 —
The Children's Hospital of Philadelphia Philadelphia Pennsylvania 19104 —
UPMC Children's Hospital of Pittsburgh Pittsburgh Pennsylvania 15224 —
Texas Children's Hospital (Baylor College of Medicine) Houston Texas 77030 —
University of Utah Salt Lake City Utah 84113 —
Seattle Children's Hospital Seattle Washington 98105 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01148550, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 4, 2026 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01148550 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →